Download Files:
Tafamidis
SKU
HY-14852-10 mg
Category Reference compound
Tags Neurological Disease, Neuronal Signaling, Transthyretin (TTR)
$66 – $495
Products Details
Product Description
– Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis[1].
Web ID
– HY-14852
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C14H7Cl2NO3
References
– [1]Bulawa, C.E., et al., Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A, 2012. 109(24): p. 9629-34.
CAS Number
– 594839-88-0
Molecular Weight
– 308.12
Compound Purity
– 99.89
SMILES
– O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O
Clinical Information
– Launched
Research Area
– Neurological Disease
Solubility
– DMSO : 37.5 mg/mL (ultrasonic)
Target
– Transthyretin (TTR)
Pathway
– Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.